BIT Computer Co., Ltd (032850.KQ)
Seoul, KR
Established in Seoul, South Korea, in 1983, BIT Computer Co., Ltd. is a specialist provider of diverse software solutions, primarily catering to the healthcare sector. Their comprehensive product suite includes a variety of hospital management systems, such as numerous Electronic Medical Record (EMR) platforms adapted for institutions ranging from small clinics to large hospitals and nursing facilities. These core offerings are enhanced by supplementary tools for tasks like insurance claim review, optimizing pharmaceutical prescriptions, intelligent nursing assistance, as well as hospital-specific enterprise resource planning (ERP) and customer relationship management (CRM) systems. The company also delivers solutions focused on patient and member engagement, encompassing cloud-based platforms, paperless clinic technology, medical image management, patient waiting systems with mobile notifications, pre-inspection services for insurance claims, and robust personal information security. Furthermore, BIT Computer provides specialized software for pharmacy management and a dedicated pharmaceutical portal. Their innovative digital health portfolio features non-contact medical services, advanced telemedicine systems, booth-based remote medical care, smart healthcare applications, employee health management tools, and medical device integration gateways.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.11% | -8.11% | -20.49% | -22.88% | -10.09% | -7.91% | -14.58% | -37.19% | -55.95% | -47.09% | -41.24% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Medical - Healthcare Information Services: +14.2%+10.8% Q3'25: +0.2% (vs Q3'24)
-
EPS growth Medical - Healthcare Information Services: +43.1%+41.7% Q3'25: -13.7% (vs Q3'24)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+14.0% Q3'25: +25.3% (vs Q3'24)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+25.2% ★ Q3'25: +17.4% (vs Q3'24)
-
ROIC Medical - Healthcare Information Services: +5.2%+16.8% ★ Q3'25: +10.4% (vs Q3'24)
-
Share dilution Medical - Healthcare Information Services: -0.1%-1.1% ★ Q3'25: -3.8% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.09× ★ Q3'25: 0.05× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-28 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-27 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-26 | A+ | 5/5 | 5/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-22 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-21 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-20 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-19 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-18 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-15 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-14 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-13 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-12 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-11 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-08 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-07 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-06 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 4/5 |
| 2026-05-04 | A+ | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hyun-Jung Cho | Chairman & CEO | — | male |
| Jin-Ok Jeon | President & CEO | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 032850.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
